 |
2-chloroethyl-3-sarcosinamide-1-nitrosourea |
|---|---|
| Trade Name | Sarmustine |
| Orphan Indication | Glioma |
| USA Market Approval | USA |
| USA Designation Date | 2001-11-15 00:00:00 |
| Sponsor | Pangene Corporation;5500 Stewart Avenue;Fremont, California, 94538 |
Related Access Program